img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
October 1, 2019
img
Indonesia Energy Corp.
(NYSE: INDO)


Financial Advisor

August 1, 2019
img
img
Stemline Therapeutics, Inc.
(Nasdaq: STML)

$76,250,000

Follow-On Offering
Co-Manager

July 1, 2019
img
img
Tonix Pharmaceuticals
(Nasdaq: TNXP)

$5,400,000

Follow-On Offering
Sole Bookrunner

July 1, 2019
img
img
Sigma Labs
(Nasdaq: SGLB)

$2,300,000

Follow-On Offering
Sole Bookrunner

June 1, 2019
img
img
Gladstone Land
(Nasdaq: LAND)

$23,460,000

Follow-On Offering
Co-Manager

June 1, 2019
img
Document Security Systems
(NYSE: DSS)

$5,859,593

Follow-On Offering
Sole Bookrunner

May 1, 2019
img
img
Medalist Diversified REIT
(Nasdaq: MDRR)

$9,199,167

Follow-On Offering
Sole Bookrunner

May 1, 2019
img
Jiayin Group Inc
(Nasdaq: JFIN)

$36,750,000

Follow-On Offering
Co-Manager

May 1, 2019
img
img
Medalist Diversified REIT
(Nasdaq: MDRR)

$1,299,998

Private Placement
Placement Agent

May 1, 2019
img
img
Genetic Technologies
(Nasdaq: GENE)

$1,180,917


Sole Bookrunner

April 1, 2019
img
img
Monaker Group
(Nasdaq: MKGI)

$1,740,000

Follow-On Offering
Co-Manager

img
img
Golden Matrix Group Inc.
(OTCPK: GMGI)

$10,000,000

Underwritten Public Offering
Sole Bookrunner

1 … 33 34 35 36
Insights
  • June 17, 2025

    D. Boral Capital acted as Exclusive Placement Agent to Brera Holdings PLC (Nasdaq: BREA) in connection with its $1.4 Million Registered Direct Offering

    Read More icon Read More icon
  • June 11, 2025

    D. Boral Capital acted as Sole Bookrunner to Aduro Clean Technologies Inc. (Nasdaq: ADUR) in connection with its $8.0 Million Follow-on Offering

    Read More icon Read More icon
  • June 10, 2025

    D. Boral Capital acted as Placement Agent in connection with a $4,850,000 Private Placement of SpaceX Series Interests

    Read More icon Read More icon
  • June 2, 2025

    D. Boral Capital Acted as Co-Placement Agent to Medicus Pharma Ltd. (Nasdaq: MDCX) in connection with its $7.0 Million Follow-On Offering

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.